PF-Atlas › Clinical Trials › NCT06569381

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

Pirfenidone Modified-Release Tablets · Phase 1

Registry ID
NCT06569381
Phase
Phase 1
Status
Completed
Drug / intervention
Pirfenidone Modified-Release Tablets
Sponsor
Overseas Pharmaceuticals, Ltd.
Start
2024-09-18

About this trial

Pirfenidone Modified-Release Tablets is evaluated in NCT06569381, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Overseas Pharmaceuticals, Ltd.. Current status: Completed.

View NCT06569381 on ClinicalTrials.gov →

Explore related

All Pirfenidone Modified-Release Tablets trialsAll IPF trials

Related trials

Pirfenidone Modified-Release Tablets — NCT06588517Pirfenidone Modified-Release Tablets — NCT06589921
Medical disclaimer. This page summarizes public trial data for NCT06569381 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.